Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 314,850 | 350,129 | 425,999 | 401,052 | 61,400 |
| Marketable Securities | 521,109 | 437,645 | 197,824 | 180,286 | 184,880 |
| Receivables | 198,524 | 4,920 | 68,644 | 43,450 | 1,310 |
| Inventories | 496,349 | 33,665 | 524 | N/A | 23,650 |
| Income taxes - deferred | 123,945 | 27,675 | 8,771 | N/A | N/A |
| Other current assets | 183,887 | 123,576 | 0 | 0 | 7,270 |
| TOTAL | $1,838,664 | $977,610 | $708,814 | $631,258 | $278,510 |
| Non-Current Assets | |||||
| PPE Net | 1,252,783 | 264,537 | 108,588 | 47,514 | 20,820 |
| Investments And Advances | 1,622,620 | 700,565 | 252,051 | 169,188 | 7,730 |
| Intangibles | 4,789,878 | 9,280 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 107,697 | 71,763 | 8,446 | 0 |
| TOTAL | $7,665,281 | $1,082,079 | $432,402 | $225,148 | $28,550 |
| Total Assets | $9,503,945 | $2,059,689 | $1,141,216 | $856,406 | $307,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63,364 | 3,886 | 3,866 | 1,737 | 1,260 |
| Accrued Expenses | 240,130 | 51,607 | 27,616 | 16,071 | 12,830 |
| TOTAL | $404,825 | $56,225 | $33,789 | $23,045 | $15,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 887,270 | 866,205 | 135,977 | 128,888 | 122,910 |
| Deferred Revenues | 7,155 | 732 | 2,307 | 4,494 | N/A |
| aiOther Non-Current Liabilities | 50,204 | 27,569 | 12,118 | 1,482 | 0 |
| TOTAL | $2,045,792 | $893,774 | $150,948 | $138,742 | $131,480 |
| Total Liabilities | $2,450,617 | $949,999 | $184,737 | $161,787 | $147,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 331,997 | 154,677 | 152,958 | N/A | N/A |
| Common Shares | 166 | 78 | 76 | 73 | 20 |
| Retained earnings | -611,921 | 263,176 | 115,086 | 13,427 | -34,710 |
| Other shareholders' equity | -1,087 | 3,764 | 1,085 | 517 | -550 |
| TOTAL | $7,053,328 | $1,109,690 | $956,479 | $694,619 | $159,970 |
| Total Liabilities And Equity | $9,503,945 | $2,059,689 | $1,141,216 | $856,406 | $307,060 |